Venture Capital INDUSTRIES

WilmerHale has been a trusted adviser to innovators, entrepreneurs and investors in technology and life sciences for more than 50 years.


Startup companies and leading investors throughout the United States and Europe rely on WilmerHale to take their ventures from founding and funding to market leadership and successful IPO or exit. Our experience advising venture-backed companies over five decades enables us to deliver guidance that is practical, business oriented and cost effective.

Our clients trust us to help them navigate the wide variety of legal challenges that arise when building a successful business. We draw on the firm's leading intellectual property, technology licensing, privacy and data security, employment, regulatory compliance, and financial services practices. And with offices in venture capital hubs including Boston, Washington DC, New York, Palo Alto, San Francisco, London, Berlin and Beijing, we provide unmatched service and responsiveness to clients. We also participate actively in local startup ecosystems, regularly facilitating introductions between investors and founders and hosting educational and social events.

Contacts

Sort By
Gammell, David

David D. Gammell

Co-Chair, Emerging Company Practice

+1 617 526 6839 (t)

david.gammell@wilmerhale.com

Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Bain, Mick

Mick Bain

Co-Chair, Corporate Practice Group

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Experience

Venture capital is a cornerstone of our corporate practice. We represent venture-backed companies and venture capital firms in industries such as big data and data analytics, software as a service, digital media, cybersecurity, robotics, financial technology, semiconductors and electronics, telecommunications and networking, life sciences, biotechnology, healthcare technology, energy, material science and many others. We leverage our global position to best serve our clients' needs and lend perspective to their business deals.

We regularly work with investors and entrepreneurs on financings ranging from seed to growth equity, venture debt, and complex strategic partner financings. We also advise leading venture capitalists on fund formation.

Our extensive experience with emerging technology companies enables us to efficiently manage standard venture capital financings and effectively navigate more complex transactions. Most importantly, we provide clients with a consistent team that provides reliable advice as they build their businesses, drawing on our deep experience in fields including intellectual property, privacy and data security, licensing, labor and employment, environmental, litigation, real estate, and tax law.

We provide advice in context. Our legal experience is bolstered by technical and scientific domain knowledge from attorneys with degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, material science, mathematics, mechanical engineering, medicine, microbiology, nuclear engineering, physics, organic chemistry and systems engineering.

Highlights

Our preeminent Venture Capital Practice consistently ranks in the top tier of law firms measured by the number of venture capital-backed companies we represent in the United States, and in Europe.

Since 2006, we have handled more than 2,800 venture financings with total proceeds in excess of $35 billion. In 2016 alone, we served as counsel in approximately 250 venture financings raising nearly $3 billion, including some of the largest and most prominent deals of the year.

Additional venture capital highlights.

Publications & News

View

June 7, 2017

Selected 2017 Life Sciences Transactions

Recognized both globally and nationally for its leading life sciences practice, WilmerHale has more than four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

June 7, 2017

Selected 2017 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution, portfolio development and litigation; defended their interests in enterprise-critical litigation; and navigated regulatory issues vital to their success.

May 26, 2017

WilmerHale Lawyers and Practices Recognized in 2017 Edition of Chambers USA

Chambers and Partners announced its rankings for the 2017 edition of Chambers USA: America's Leading Lawyers for Business, with WilmerHale listed among the nation's best in 50 practice area categories. Chambers also ranked 86 WilmerHale lawyers as leaders in their respective fields.

May 17, 2017

WilmerHale Ranks Among Top Three Life Sciences Law Firms for Second Consecutive Year

The index—launched last year by Lake Whillans and Breaking Media (publisher of MedCity News and Above the Law)—identifies which law firms are the most active and relevant for life sciences companies.

May 11, 2017

WilmerHale Counsels Changing Environments in 2.5M Seed Financing

Changing Environments, dba Soofa, a Cambridge, Massachusetts-based startup offering smart and sustainable hardware and software solutions to make smart cities a reality, announced a $2.5 million seed financing.

May 10, 2017

Alumni from iRobot and HubSpot Launch Owl Labs and Announce $6M Series A Funding

WilmerHale client Owl Labs announced a $6M Series A financing led by Matrix Partners.

May 8, 2017

WilmerHale Counsels Exonics Therapeutics in $5M Seed Financing

The newly formed biotechnology company focused on developing gene editing technologies to permanently correct a majority of mutations causing Duchenne muscular dystrophy and other neuromuscular diseases, announced a commitment of $5 million in seed financing from CureDuchenne Ventures.

May 1, 2017

WilmerHale Reps WorkMarket in $25M in Series D Funding

WorkMarket, Inc., an online platform and marketplace for businesses to manage freelancers, contractors and consultants, received $25 million in its latest round of funding.

April 28, 2017

2017 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

April 28, 2017

2017 Venture Capital Report

The 2017 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as a look at the following issues: steps startups should take now if they plan to secure a Series A round in 2017; common structures for management carve-out plans; best practices for private companies setting option exercise prices; the benefits of investing in qualified small business stock; and trends in venture capital financing terms, convertible debt terms and VC-backed company M&A deal terms.